Bristol-Myers Said To Renege On $450M Milestone Promise
By Rae Ann Varona · December 10, 2024, 10:45 PM EST
Former security holders of a biotechnology company Bristol-Myers Squibb acquired in 2016 hauled the pharmaceutical giant into Delaware's Court of Chancery on Monday, accusing it of using "patent prosecution sleight of...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login